Literature DB >> 29138117

Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.

Rajib Paul1, Banashree Chetia Phukan2, Arokiasamy Justin Thenmozhi3, Thamilarasan Manivasagam3, Pallab Bhattacharya4, Anupom Borah5.   

Abstract

AIM: Hyperhomocysteinemia and homocysteine (Hcy) mediated dopaminergic neurotoxicity is a matter of concern in the pathophysiology of Parkinson's disease (PD). Our previous study established the involvement of oxidative stress in the substantia nigra (SN) of Hcy rat model of PD; however, the role of antioxidants, such as melatonin, was not tested in this model. MAIN
METHODS: Melatonin (10, 20 and 30mg/kg, i.p.) was administered to rats injected with Hcy in right SN (1.0μmol in 2μl saline) to investigate its potency in attenuating the behavioral abnormalities, dopamine depletion and oxidative stress prompted by Hcy. KEY
FINDINGS: Treatment of melatonin protected against nigral dopamine loss and replenished the striatal dopamine loss that resulted in amelioration of rotational behavioral bias in Hcy denervated animals. Melatonin administration significantly improved mitochondrial complex-I activity and protected the SN neurons from the toxic insults of oxidative stress induced by Hcy. Amelioration of oxidative stress by melatonin in Hcy-infused SN was bought by dose-dependently scavenging of hydroxyl radicals, restoration of glutathione level and elevation in the activity of antioxidant enzymes. SIGNIFICANCE: The observations bring into light the significant neuroprotective potentials of melatonin in Hcy model of PD which is attributed to the attenuation of oxidative stress in SN.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Antioxidant; Complex-I; Dopamine; Hydroxyl radical; Neuroprotection; Rotational bias

Mesh:

Substances:

Year:  2017        PMID: 29138117     DOI: 10.1016/j.lfs.2017.11.016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

Review 1.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

2.  Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.

Authors:  Antonio Gonzalez
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

Review 3.  Clinical trials in REM sleep behavioural disorder: challenges and opportunities.

Authors:  Aleksandar Videnovic; Yo-El S Ju; Isabelle Arnulf; Valérie Cochen-De Cock; Birgit Högl; Dieter Kunz; Federica Provini; Pietro-Luca Ratti; Mya C Schiess; Carlos H Schenck; Claudia Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-05-13       Impact factor: 10.154

4.  Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.

Authors:  Banashree Chetia Phukan; Ankumoni Dutta; Satarupa Deb; Rubul Saikia; Muhammed Khairujjaman Mazumder; Rajib Paul; Pallab Bhattacharya; Rajat Sandhir; Anupom Borah
Journal:  Exp Brain Res       Date:  2021-10-11       Impact factor: 1.972

5.  The effects of regular swimming exercise and melatonin on the neurons localized in the striatum of hemiparkinsonian rats.

Authors:  Sinem Gergin; Özlem Kirazlı; Hatice Boracı; Sercan Doğukan Yıldız; Hasan Raci Yananlı; Ümit Süleyman Şehirli
Journal:  Anat Sci Int       Date:  2022-10-12       Impact factor: 1.693

Review 6.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

Review 7.  Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms.

Authors:  Omid Reza Tamtaji; Russel J Reiter; Reza Alipoor; Ehsan Dadgostar; Ebrahim Kouchaki; Zatollah Asemi
Journal:  Cell Mol Neurobiol       Date:  2019-08-06       Impact factor: 5.046

8.  Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson's Disease Rat Model Through AKT/GSK3β Signaling.

Authors:  Xing-Zhi Guo; Chang Shan; Yan-Fang Hou; Geng Zhu; Bei Tao; Li-Hao Sun; Hong-Yan Zhao; Guang Ning; Sheng-Tian Li; Jian-Min Liu
Journal:  Front Mol Neurosci       Date:  2018-09-27       Impact factor: 5.639

Review 9.  Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

10.  Pathway analysis identifies altered mitochondrial metabolism, neurotransmission, structural pathways and complement cascade in retina/RPE/ choroid in chick model of form-deprivation myopia.

Authors:  Loretta Giummarra; Sheila G Crewther; Nina Riddell; Melanie J Murphy; David P Crewther
Journal:  PeerJ       Date:  2018-06-27       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.